Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
RESILIENCE Project will participate on Friday, September 29th in the XIV European Researchers Night in Madrid with an activity in which the public of all ages can attend, free of charge, with prior registration. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” where we will have the opportunity of getting closer […]
